In accord with our normal clinical practice in this situation, blood samples were obtained for biochemical liver function tests at two weekly intervals after the initial exposure to cryoprecipitate. In the eighth week, the AST became abnormal at 92 IU/l. When seen one week later the patient gave a history of nausea, malaise, and anorexia for the previous five days and recurrent vomiting for two days. She also described dark urine, looseness of stools and shivering attacks. On examination, she was jaundiced and tender in the epigastrium but the liver was A liver biopsy was performed two years after the original exposure to cryoprecipitate and it was to limit further exposure to blood products that the biopsy was covered with DDAVP.7 This agent raised the baseline factor VIII: C level from 40 to 100 U/dl and thus it was possible to maintain an adequate level of factor VIII: C for 72 hours with u.
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